Patents by Inventor Jochen Matthias SCHER

Jochen Matthias SCHER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulations comprising CCR3 antagonists
    Patent number: 11612596
    Abstract: The present invention relates to pharmaceutical compositions containing one or more compounds of formula 1 wherein R1 is H, C1-6-alkyl, C0-4-alkyl-C3-6-cycloalkyl, C1-6-haloalkyl; R2 is H, C1-6-alkyl; X is an anion selected from the group consisting of chloride or ½ dibenzoyltartrate; j is 1 or 2; and processes for the preparation thereof, and their use to treat diseases connected with the CCR3 receptor.
    Type: Grant
    Filed: April 29, 2020
    Date of Patent: March 28, 2023
    Assignee: Alkahest, Inc.
    Inventors: Alfred Fetscher, Jochen Matthias Scher
  • Pharmaceutical Formulations Comprising CCR3 Antagonists
    Publication number: 20200253950
    Abstract: The present invention relates to pharmaceutical compositions containing one or more compounds of formula 1 wherein R1 is H, C1-6-alkyl, C0-4-alkyl-C3-6-cycloalkyl, C1-6-haloalkyl; R2 is H, C1-6-alkyl; X is an anion selected from the group consisting of chloride or ½ dibenzoyltartrate; j is 1 or 2; and processes for the preparation thereof, and their use to treat diseases connected with the CCR3 receptor.
    Type: Application
    Filed: April 29, 2020
    Publication date: August 13, 2020
    Inventors: Alfred Fetscher, Jochen Matthias Scher
  • Pharmaceutical Formulations Comprising CCR3 Antagonists
    Publication number: 20190151300
    Abstract: The present invention relates to pharmaceutical compositions containing one or more compounds of formula 1 wherein R1 is H, C1-6-alkyl, C0-4-alkyl-C3-6-cycloalkyl, C1-6-haloalkyl; R2 is H, C1-6-alkyl; X is an anion selected from the group consisting of chloride or ½ dibenzoyltartrate; j is 1 or 2; and processes for the preparation thereof, and their use to treat diseases connected with the CCR3 receptor.
    Type: Application
    Filed: December 28, 2018
    Publication date: May 23, 2019
    Inventors: Alfred FETSCHER, Jochen Matthias SCHER
  • Pharmaceutical formulations comprising CCR3 antagonists
    Patent number: 10213421
    Abstract: The present invention relates to pharmaceutical compositions containing one or more compounds of formula 1 wherein R1 is H, C1-6-alkyl, C0-4-alkyl-C3-6-cycloalkyl, C1-6-haloalkyl; R2 is H, C1-6-alkyl; X is an anion selected from the group consisting of chloride or ½ dibenzoyltartrate j is 1 or 2. processes for the preparation thereof, and their use to treat diseases connected with the CCR3 receptor.
    Type: Grant
    Filed: March 27, 2013
    Date of Patent: February 26, 2019
    Assignee: Alkahest, Inc.
    Inventors: Alfred Fetscher, Jochen Matthias Scher
  • PHARMACEUTICAL FORMULATIONS COMPRISING CCR3 ANTAGONISTS
    Publication number: 20130266646
    Abstract: The present invention relates to pharmaceutical compositions containing one or more compounds of formula 1 wherein R1 is H, C1-6-alkyl, C0-4-alkyl-C3-6-cycloalkyl, C1-6-haloalkyl; R2 is H, C1-6-alkyl; X is an anion selected from the group consisting of chloride or ½ dibenzoyltartrate j is 1 or 2.
    Type: Application
    Filed: March 27, 2013
    Publication date: October 10, 2013
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Alfred FETSCHER, Jochen Matthias SCHER